Literature DB >> 23349251

Out of pocket, out of sight? An unmeasured component of the burden of cancer.

Matthew P Banegas, K Robin Yabroff.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23349251      PMCID： PMC3611849          DOI： 10.1093/jnci/djs641

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  17 in total

1.  National estimates of out-of-pocket health care expenditure burdens among nonelderly adults with cancer: 2001 to 2008.

Authors:  Didem S M Bernard; Stacy L Farr; Zhengyi Fang
Journal:  J Clin Oncol       Date:  2011-05-31       Impact factor: 44.544

2.  A cross-national perspective on cost of illness: a comparison of studies from The Netherlands, Australia, Canada, Germany, United Kingdom, and Sweden.

Authors:  Johan J Polder; Willem Jan Meerding; Luc Bonneux; Paul J van der Maas
Journal:  Eur J Health Econ       Date:  2005-09

3.  Employment-contingent health insurance, illness, and labor supply of women: evidence from married women with breast cancer.

Authors:  Cathy J Bradley; David Neumark; Zhehui Luo; Heather L Bednarek
Journal:  Health Econ       Date:  2007-07       Impact factor: 3.046

4.  Limits on Medicare's ability to control rising spending on cancer drugs.

Authors:  Peter B Bach
Journal:  N Engl J Med       Date:  2009-01-27       Impact factor: 91.245

5.  Patient and plan characteristics affecting abandonment of oral oncolytic prescriptions.

Authors:  Sonya Blesser Streeter; Lee Schwartzberg; Nadia Husain; Michael Johnsrud
Journal:  J Oncol Pract       Date:  2011-05       Impact factor: 3.840

6.  Expensive cancer drugs: a comparison between the United States and the United Kingdom.

Authors:  Ruth R Faden; Kalipso Chalkidou; John Appleby; Hugh R Waters; Jonathon P Leider
Journal:  Milbank Q       Date:  2009-12       Impact factor: 4.911

7.  Forgoing medical care because of cost: assessing disparities in healthcare access among cancer survivors living in the United States.

Authors:  Kathryn E Weaver; Julia H Rowland; Keith M Bellizzi; Noreen M Aziz
Journal:  Cancer       Date:  2010-07-15       Impact factor: 6.860

8.  The Medical Expenditure Panel Survey (MEPS) experiences with cancer survivorship supplement.

Authors:  K Robin Yabroff; Emily Dowling; Juan Rodriguez; Donatus U Ekwueme; Helen Meissner; Anita Soni; Catherine Lerro; Gordon Willis; Laura P Forsythe; Laurel Borowski; Katherine S Virgo
Journal:  J Cancer Surviv       Date:  2012-07-19       Impact factor: 4.442

9.  Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis.

Authors:  Veena Shankaran; Sanjay Jolly; David Blough; Scott D Ramsey
Journal:  J Clin Oncol       Date:  2012-03-12       Impact factor: 44.544

10.  Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs.

Authors:  Scott R Berry; Chaim M Bell; Peter A Ubel; William K Evans; Eric Nadler; Elizabeth L Strevel; Peter J Neumann
Journal:  J Clin Oncol       Date:  2010-08-09       Impact factor: 44.544
View more
  8 in total

1.  Spending for Advanced Cancer Diagnoses: Comparing Recurrent Versus De Novo Stage IV Disease.

Authors:  Michael J Hassett; Matthew Banegas; Hajime Uno; Shicheng Weng; Angel M Cronin; Maureen O'Keeffe Rosetti; Nikki M Carroll; Mark C Hornbrook; Debra P Ritzwoller
Journal:  J Oncol Pract       Date:  2019-05-20       Impact factor: 3.840

2.  Bridging the gap between financial distress and available resources for patients with cancer: a qualitative study.

Authors:  Sophia K Smith; Jonathan Nicolla; S Yousuf Zafar
Journal:  J Oncol Pract       Date:  2014-05-27       Impact factor: 3.840

3.  Predictors of financial difficulties and work modifications among cancer survivors in the United States.

Authors:  Robin L Whitney; Janice F Bell; Sarah C Reed; Rebecca Lash; Richard J Bold; Katherine K Kim; Andra Davis; David Copenhaver; Jill G Joseph
Journal:  J Cancer Surviv       Date:  2015-07-19       Impact factor: 4.442

4.  National trends in spending on and use of oral oncologics, first quarter 2006 through third quarter 2011.

Authors:  Rena M Conti; Adam J Fein; Sumita S Bhatta
Journal:  Health Aff (Millwood)       Date:  2014-10       Impact factor: 6.301

5.  Medical Care Costs for Recurrent versus De Novo Stage IV Cancer by Age at Diagnosis.

Authors:  Debra P Ritzwoller; Paul A Fishman; Matthew P Banegas; Nikki M Carroll; Maureen O'Keeffe-Rosetti; Angel M Cronin; Hajime Uno; Mark C Hornbrook; Michael J Hassett
Journal:  Health Serv Res       Date:  2018-07-24       Impact factor: 3.402

6.  A composite measure of personal financial burden among patients with stage III colorectal cancer.

Authors:  Christine M Veenstra; Scott E Regenbogen; Sarah T Hawley; Jennifer J Griggs; Mousumi Banerjee; Ikuko Kato; Kevin C Ward; Arden M Morris
Journal:  Med Care       Date:  2014-11       Impact factor: 2.983

Review 7.  A Narrative Review of the Confluence of Breast Cancer and Low-wage Employment and Its Impact on Receipt of Guideline-recommended Treatment.

Authors:  Robin C Vanderpool; Jennifer E Swanberg; Mara D Chambers
Journal:  Glob Adv Health Med       Date:  2013-09

Review 8.  Strategies to Mitigate Chemotherapy and Radiation Toxicities That Affect Eating.

Authors:  Peter M Anderson; Stefanie M Thomas; Shauna Sartoski; Jacob G Scott; Kaitlin Sobilo; Sara Bewley; Laura K Salvador; Maritza Salazar-Abshire
Journal:  Nutrients       Date:  2021-12-08       Impact factor: 5.717
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.